ARCHIVES

ASCO Annual Meeting: New Approaches For Treatment of Hematologic Malignancies

This article is from The Cancer Letter archive.

Vol. 29 No. 6 | June 30, 2006

Download PDF Visit The Full Archive

Related Articles

Study: CYP2D6 Genotypes Are Unreliable Predictors of Benefit

March 30, 2012

Hammer Agrees To Bush Request for FDA Probe

July 15, 1988

Klausner, Nathan Discuss Challenge of Cancer Research In the “Post-Genome World”

January 15, 1999

Elderly Men Say Physicians Are Recommending PSA Tests

December 26, 2003

In Brief: Robert Bast Succeeds Singleton As Director Of Duke Cancer Center; Robert Bell Deputy

August 14, 1987

FDA seeks support for reorganization of cancer programs, but debate continues.

July 9, 2004